Immunogenicity Assessment for the Successful Development of BiosimilarsWednesday, 27 June 2012 at 11:15 Add to Calendar ▼2012-06-27 00:00:002012-06-27 01:00:00Europe/LondonImmunogenicity Assessment for the Successful Development of Biosimilars Stem Cells and Bioprocessing Europe in London, EnglandLondon, EnglandSELECTBIOenquiries@selectbiosciences.com Successful development of biosimilars requires the establishment of a validated and standardized assay that allows direct comparisons of the relative potency and immunogenicity of innovator molecules and biosimilars as illustrated by case studies for interferon beta products and TNF-alpha antagonists. |